These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30733049)

  • 1. Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis.
    Frilling A; Clift AK; Braat AJAT; Alsafi A; Wasan HS; Al-Nahhas A; Thomas R; Drymousis P; Habib N; Tait PN
    HPB (Oxford); 2019 Jul; 21(7):773-783. PubMed ID: 30733049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
    Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R
    Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1617-1623. PubMed ID: 28132407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.
    Memon K; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Sato KT; Gupta R; Nikolaidis P; Miller FH; Yaghmai V; Gates VL; Atassi B; Newman S; Omary RA; Benson AB; Salem R
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):887-94. PubMed ID: 22137020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres.
    Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S
    J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center.
    Arslan N; Emi M; Alagöz E; Ustünsöz B; Oysul K; Arpaci F; Uğurel S; Beyzadeoğlu M; Ozgüven MA
    Vojnosanit Pregl; 2011 Apr; 68(4):341-8. PubMed ID: 21627019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
    Kim AY; Frantz S; Brower J; Akhter N
    J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
    Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.
    Bester L; Meteling B; Pocock N; Saxena A; Chua TC; Morris DL
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):72-80. PubMed ID: 23374558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
    Peker A; Çiçek O; Soydal Ç; Küçük NÖ; Bilgiç S
    Diagn Interv Radiol; 2015; 21(1):54-9. PubMed ID: 25430526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
    Ozao-Choy J; Friedman ML; Kim AS; Wachsman A; Wolin EM; Yu R; Nissen NN; Colquhoun SD
    Pancreas; 2013 Mar; 42(2):358-60. PubMed ID: 23407486
    [No Abstract]   [Full Text] [Related]  

  • 13. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study.
    Kayaleh R; Krzyston H; Rishi A; Naziri J; Frakes J; Choi J; El-Haddad G; Parikh N; Sweeney J; Kis B
    J Vasc Interv Radiol; 2020 Jul; 31(7):1060-1068. PubMed ID: 32534978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.
    Devcic Z; Rosenberg J; Braat AJ; Techasith T; Banerjee A; Sze DY; Lam MG
    J Nucl Med; 2014 Sep; 55(9):1404-10. PubMed ID: 25012459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
    Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
    BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver radioembolization using 90Y resin microspheres in elderly patients: tolerance and outcome.
    Iñarrairaegui M; Bilbao JI; Rodríguez M; Benito A; Sangro B
    Hosp Pract (1995); 2010; 38(3):103-9. PubMed ID: 20890058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
    Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326
    [No Abstract]   [Full Text] [Related]  

  • 19. Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience.
    Pieper CC; Meyer C; Wilhelm KE; Block W; Nadal J; Ahmadzadehfar H; Willinek WA; Schild HH
    J Vasc Interv Radiol; 2016 Sep; 27(9):1305-1315. PubMed ID: 27461588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yttrium-90 Radioembolization with Resin Microspheres without Routine Embolization of the Gastroduodenal Artery.
    Ward TJ; Louie JD; Sze DY
    J Vasc Interv Radiol; 2017 Feb; 28(2):246-253. PubMed ID: 27884683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.